Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product) |
Is a |
Vaccine product containing only live attenuated Rotavirus antigen (medicinal product) |
true |
Inferred relationship |
Some |
|
|
Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product) |
Plays role |
Active immunity stimulant role (role) |
true |
Inferred relationship |
Some |
|
|
Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of live attenuated human-bovine reassortant Rotavirus serotype P1A[8] (substance) |
true |
Inferred relationship |
Some |
1 |
|
Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of live attenuated human-bovine reassortant Rotavirus serotype G1 (substance) |
true |
Inferred relationship |
Some |
2 |
|
Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of live attenuated human-bovine reassortant Rotavirus serotype G2 (substance) |
true |
Inferred relationship |
Some |
3 |
|
Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of live attenuated human-bovine reassortant Rotavirus serotype G3 (substance) |
true |
Inferred relationship |
Some |
4 |
|
Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of live attenuated human-bovine reassortant Rotavirus serotype G4 (substance) |
true |
Inferred relationship |
Some |
5 |
|